Access to a new COVID-19 drug will be expanded in low- and middle-income countries following a voluntary licensing agreement between the pharmaceutical company Pfizer and a UN-backed global health initiative, announced in Geneva on Tuesday. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.